6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      150 Number needed to treat associated with ixekizumab and etanercept from UNCOVER-2 and UNCOVER-3 Phase III trials in the treatment of moderate-to-severe psoriasis

      , ,
      Journal of Investigative Dermatology
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Journal of Investigative Dermatology
          Journal of Investigative Dermatology
          Elsevier BV
          0022202X
          May 2016
          May 2016
          : 136
          : 5
          : S27
          Article
          10.1016/j.jid.2016.02.177
          d1a694bb-511d-4942-ba8b-3e8f6a9fbe77
          © 2016

          https://www.elsevier.com/tdm/userlicense/1.0/

          https://www.elsevier.com/open-access/userlicense/1.0/

          History

          Comments

          Comment on this article